Home › Funds › Foresight Global Investors › NVS
Foresight Global Investors position in NVS
NOVARTIS AG · Health Care
Foresight Global Investors reported holding 126,790 shares of NVS (NOVARTIS AG) in its Q3 2026 13F filing — a position valued at US$18.1M, representing 17.44% of its reported portfolio and ranking #1 among its reported holdings. Foresight Global Investors has disclosed NVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Foresight Global Investors's NVS position evolved
Foresight Global Investors first disclosed a stake in NVS in Q3 2023 at 97,500 shares (US$9.4M). The position peaked in Q1 2026 at 172,053 shares, worth US$26.3M. Across 13 filings, Foresight Global Investors increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 126,790 shares valued at US$18.1M — a reduction of -26,903 shares quarter over quarter.. Notable position changes include a 35% increase in Q4 2023 (shares fell 5% over the following quarter), a 50% increase in Q1 2024 (shares rose 11% over the following quarter), a 31% increase in Q3 2024 (shares fell 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 97.50K | $9.40M | New |
| Q4 2023 | 131.97K | $13.33M | Add |
| Q1 2024 | 197.38K | $19.09M | Add |
| Q2 2024 | 171.30K | $18.24M | Reduce |
| Q3 2024 | 224.82K | $25.86M | Add |
| Q4 2024 | 232.37K | $22.61M | Add |
| Q1 2025 | 187.82K | $20.94M | Reduce |
| Q2 2025 | 164.92K | $19.96M | Reduce |
| Q3 2025 | 171.68K | $22.02M | Add |
| Q4 2025 | 172.08K | $23.73M | Hold |
| Q1 2026 | 172.05K | $26.28M | Hold |
| Q2 2026 | 153.69K | $24.09M | Reduce |
| Q3 2026 | 126.79K | $18.08M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NVS and 13F data
NVS (NOVARTIS AG) is a Health Care company. 20 other funds we track also report a position in NVS — the largest reported positions include Fisher Asset Management, LLC (US$2.39B), PRIMECAP MANAGEMENT CO/CA/ (US$938.9M), LOOMIS SAYLES & CO L P (US$689.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NVS
- Fisher Asset Management, LLC 16.76M sh · $2.39B · Q3 2026
- PRIMECAP MANAGEMENT CO/CA/ 6.59M sh · $938.89M · Q3 2026
- LOOMIS SAYLES & CO L P 4.83M sh · $689.20M · Q3 2026
- Cullen Capital Management, LLC 1.95M sh · $278.55M · Q3 2026
- WCM INVESTMENT MANAGEMENT, LLC 1.72M sh · $250.18M · Q3 2026
More on Foresight Global Investors
FAQ
How long has Foresight Global Investors held NVS?
Foresight Global Investors has disclosed NVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Foresight Global Investors's current position in NVS?
As of Q3 2026, Foresight Global Investors holds 126.79K shares of NVS (NOVARTIS AG), valued at $18.08M, representing 17.44% of its reported portfolio and ranking #1.
Has Foresight Global Investors been buying or selling NVS?
In the latest 13F filing (Q3 2026), Foresight Global Investors reduced its position in NVS. The position peaked in Q1 2026 at 172.05K shares.
Which other funds hold NVS?
Other major institutional holders of NVS include Fisher Asset Management, LLC, PRIMECAP MANAGEMENT CO/CA/, LOOMIS SAYLES & CO L P, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.